Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TRAZODONE HYDROCHLORIDE USP, with a corresponding US DMF Number 15701.
Remarkably, this DMF maintains an Active status since its submission on November 02, 2001, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 30, 2012, and payment made on November 06, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II